Astrazeneca Pharma India Shows Mixed Technical Outlook Amid Strong Performance Metrics
Astrazeneca Pharma India has recently experienced a change in evaluation, influenced by its technical trends. The company has shown strong performance with significant returns year-to-date and over the past year, alongside positive financial metrics and consistent growth in net sales and profit after tax.
Astrazeneca Pharma India has recently undergone an adjustment in evaluation, reflecting changes in its underlying technical trends. The stock's technical indicators have shown a transition, with the MACD remaining bullish on both weekly and monthly bases. However, the KST has indicated a mildly bearish trend on a weekly and monthly scale, suggesting a mixed technical outlook.In terms of performance, Astrazeneca Pharma India has demonstrated notable returns over various periods. For instance, the stock has achieved a return of 25.77% year-to-date and 19.32% over the past year, significantly outperforming the BSE500 index. The company's financial metrics reveal a strong management efficiency, highlighted by a high return on equity (ROE) of 20.34% and a low debt-to-equity ratio, indicating a solid financial foundation.
Additionally, Astrazeneca Pharma India has reported positive results for the last three consecutive quarters, with a notable growth in net sales and profit after tax. Despite its strong performance, the stock is trading at a premium compared to its peers, with a price-to-book value of 29.9, reflecting its expensive valuation in the current market context.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
